drugset
drugset / Trial / NCT06050343

Comparative Study of Rinsulin R (GEROPHARM) and Humulin Regular (Eli Lilly) Euglycemic Hyperinsulinemic Clamp Method

NCT06050343 ↗

Completed 20 enrolled Geropharm
RandomizedCrossoverDouble-blindBasic science

Summary

Pharmacokinetics and pharmacodynamics of Rinsulin® R, injection solution, 100 IU / ml (GEROPHARM LLC, Russia) and Humulin® Regular, injection solution, 100 IU / ml (Lilly France ", France) using the euglycemic hyperinsulinemic clamp method.

Timeline

Start
2018-02-19
Primary completion
2018-05-04
Completion
2018-05-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Humulin® Regular Unknown 0.3 iu/kg Subcutaneous
Subject Rinsulin® R Unknown 0.3 iu/kg Subcutaneous

Indications

No indication recorded.